ONEMEDNET CORPORATION Crypto Asset Realized And Unrealized Gain Loss Nonoperating
ONEMEDNET CORPORATION (ONMD) reported Crypto Asset Realized And Unrealized Gain Loss Nonoperating of $45.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating · last filed 2026-08-14
- ONEMEDNET CORPORATION crypto asset realized and unrealized gain loss nonoperating for the quarter ending 2026-06-30 was $45.00K.
- ONEMEDNET CORPORATION crypto asset realized and unrealized gain loss nonoperating for the quarter ending 2026-03-31 was $102.00K.
- ONEMEDNET CORPORATION crypto asset realized and unrealized gain loss nonoperating for the quarter ending 2025-12-31 was -$163.00K, a 117.68% decline year-over-year.
- ONEMEDNET CORPORATION crypto asset realized and unrealized gain loss nonoperating for the quarter ending 2025-09-30 was $55.00K.
| Period end | Crypto Asset Realized And Unrealized Gain Loss Nonoperating 3 month | Crypto Asset Realized And Unrealized Gain Loss Nonoperating 6 month | Crypto Asset Realized And Unrealized Gain Loss Nonoperating 9 month | Crypto Asset Realized And Unrealized Gain Loss Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $45.00K 10-Q · filed 2026-08-14 | $147.00K 10-Q · filed 2026-08-14 | -$16.00K derived: sum of 3 quarters · filed 2026-08-14 | $39.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $102.00K 10-Q · filed 2026-08-14 | -$61.00K derived: sum of 2 quarters · filed 2026-08-14 | -$6.00K derived: sum of 3 quarters · filed 2026-08-14 | -$180.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$163.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$108.00K derived: sum of 2 quarters · filed 2026-07-08 | -$282.00K derived: sum of 3 quarters · filed 2026-08-14 | -$945.00K S-1/A · filed 2026-07-08 |
| 2025-09-30 | $55.00K 10-Q · filed 2025-11-14 | -$119.00K derived: sum of 2 quarters · filed 2026-08-14 | -$782.00K 10-Q · filed 2025-11-14 | $141.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$174.00K 10-Q · filed 2026-08-14 | -$837.00K 10-Q · filed 2026-08-14 | $86.00K derived: sum of 3 quarters · filed 2026-08-14 | -$38.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$662.00K S-1/A · filed 2026-07-08 | $260.00K derived: sum of 2 quarters · filed 2026-07-08 | $136.00K derived: sum of 3 quarters · filed 2026-07-08 | |
| 2024-12-31 | $922.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $798.00K derived: sum of 2 quarters · filed 2026-07-08 | $798.00K S-1/A · filed 2026-07-08 | |
| 2024-09-30 | -$124.00K 10-Q · filed 2025-11-14 | -$124.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |